Everything on Healthcare Innovation

Pharmaceutical manufacturers are shifting focus from standard generics to complex biosimilars, leveraging advanced manufacturing to capture high-margin markets ahead of patent cliffs.

Impact: Early pipeline development and regulatory preparation will determine market leadership and pricing power in the upcoming biosimilar expansion cycle.

— from AI Chip Valuations, Pharma Biosimilars & Corporate Pivots · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· May 15, 2026